Isracann Biosciences Inc. Sustainability Profile
Isracann Biosciences Inc., a prominent player in the cannabis industry, is headquartered in California and operates primarily in Israel. Founded in 2018, the company has quickly established itself as a leader in the cultivation and production of high-quality cannabis products. Isracann focuses on innovative agricultural practices and advanced extraction techniques, setting its offerings apart in a competitive market. The company’s core services include the development of premium cannabis strains and the production of cannabinoid-based products, catering to both medical and recreational users. With a commitment to sustainability and quality, Isracann has achieved significant milestones, including strategic partnerships and expansions in key operational regions. As a forward-thinking entity in the cannabis sector, Isracann Biosciences Inc. continues to enhance its market position through unique product offerings and a dedication to excellence.
DitchCarbon Score
How does Isracann Biosciences Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Isracann Biosciences Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Isracann Biosciences Inc.'s reported carbon emissions
Isracann Biosciences Inc., headquartered in California, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi). As there are no emissions data or climate pledges available, Isracann's current climate strategy remains unclear. The absence of reported emissions and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate action plan. In the context of the cannabis industry, where sustainability and environmental responsibility are increasingly important, Isracann Biosciences Inc. may need to consider establishing measurable targets and commitments to align with industry standards and stakeholder expectations.
How Carbon Intensive is Isracann Biosciences Inc.'s Industry?
How Carbon Intensive is Isracann Biosciences Inc.'s Location?
Isracann Biosciences Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Isracann Biosciences Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
